China SXT Pharmaceuticals, Inc. (SXTC) Research

Established in 2005 and headquartered in Taizhou, China, China SXT Pharmaceuticals, Inc. operates as a pharmaceutical company with a comprehensive focus on traditional Chinese medicine pieces (TCMP). Its activities span the entire process, from research and development to the production, marketing, and distribution of these products across China. The company's offerings include a range of TCMP products categorized as advanced, fine, or regular, alongside a wide assortment of raw medicinal materials. Examples of these raw materials include SanQiFen, HongQi, SuMu, JiangXiang, and numerous others like ChuanBeiMu, RenShen, and JueMingZi. These products are sold under recognized brand names such as Suxuantang, Hui Chun Tang, and Tong Ren Tang. China SXT Pharmaceuticals distributes its goods to a diverse clientele, including other pharmaceutical companies, various chain pharmacies, hospitals, and specialized pharmaceutical distributors.

Market snapshot

Symbol
SXTC
Price
$2.23
Day change
+0.45%
Market cap
$1.7M
P/E ratio
-2.18x
52-week range
1.25-1047
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Atlantic International Corp. (ATLN)
  • Anteris Technologies Global Corp. (AVR)
  • Cybin Inc. (CYBN)
  • Fate Therapeutics, Inc. (FATE)
  • Innate Pharma S.A. (IPHA)
  • Incannex Healthcare Limited (IXHL)
  • Milestone Pharmaceuticals Inc. (MIST)
  • Nuvectis Pharma, Inc. (NVCT)

Recent insider activity

  • Pan Xiaodong Sean — trade (0 shares) on 2022-01-31
  • Zhou Feng Felix — trade (0 shares) on 2017-07-04
  • Chee Yong Lip — trade (0 shares) on 2025-01-20
  • Ji Xiaodong — trade (0 shares) on 2021-05-22
  • Liu Tong Tony — trade (0 shares) on 2022-05-10

Open China SXT Pharmaceuticals, Inc. (SXTC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.